L. López-Gómez

发表

Phase II randomised trial of raltitrexed–oxaliplatin vs raltitrexed–irinotecan as first-line treatment in advanced colorectal cancer

J. Feliu, A. Pèlegrin, M. González-Barón, 2005, British Journal of Cancer.

Irinotecan plus raltitrexed as first-line treatment in advanced colorectal cancer: a phase II study

J. Feliu, C. Pericay, J. Sanchez, 2004, British Journal of Cancer.

NeoHx study: Perioperative treatment with trastuzumab in combination with capecitabine and oxaliplatin (XELOX-T) in patients with HER2 resectable stomach or esophagogastric junction (EGJ) adenocarcinoma—R0 resection, pCR, and toxicity analysis.

M. Alsina, F. Rivera, J. Gallego, 2013 .

Resolution of left and right ventricular thrombosis secondary to hypereosinophilic syndrome (lymphoproliferative variant) with reduced intensity conditioning allogenic stem cell transplantation

J. Bergua, J. J. Gómez-Barrado, L. López-Gómez, 2008, Annals of Hematology.

XELOX (capecitabine and oxaliplatin) as 1st line treatment for elderly patients (pts) with advanced/metastatic colorectal cancer (MCRC).

J. Feliu, M. González-Barón, P. Escudero, 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

NEOHX study: Perioperative treatment with trastuzumab in combination with capecitabine and oxaliplatin (XELOX-T) in patients with HER-2 resectable stomach or esophagogastric junction (EGJ) adenocarcinoma—18 m DFS analysis.

M. Alsina, F. Rivera, E. Aranda, 2015 .

Long‐term complication in follicular lymphoma: assessing the risk of secondary neoplasm in 242 patients treated or not with 90‐yttrium‐ibritumomab‐tiuxetan

M. Andrade-Campos, P. Liévano, P. Giraldo, 2016, European journal of haematology.

Patients Older Than 65 Years With Non-Hodgkin Lymphoma Are Suitable for Treatment With (90)Yttrium-Ibritumumab Tiuxetan: A Single-Institution Experience.

M. Andrade-Campos, P. Liévano, P. Giraldo, 2015, Clinical lymphoma, myeloma & leukemia.

Long-term efficacy of 90Y ibritumomab tiuxetan therapy in follicular non-Hodgkin lymphoma and health-related quality of life

M. Andrade-Campos, P. Giraldo, L. López-Gómez, 2014, Annals of Hematology.

XELOX (capecitabine plus oxaliplatin) as first-line treatment for elderly patients over 70 years of age with advanced colorectal cancer

J. Feliu, E. Casado, M. González-Barón, 2006, British Journal of Cancer.

Capecitabine as first-line treatment for patients older than 70 years with metastatic colorectal cancer: an oncopaz cooperative group study.

J. Feliu, R. López, E. Casado, 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Phase II study of a fixed dose-rate infusion of gemcitabine associated with erlotinib in advanced pancreatic cancer

J. Feliu, M. González-Barón, J. Castro, 2010, Cancer Chemotherapy and Pharmacology.